2023-09-05 10:13:43 ET
More on Arcturus, CSL, etc.
- CSL: Watch Out For Positive Surprises
- CSL Limited ( OTCQX:CSLLY ) Q4 2023 Earnings Call Transcript
- CSL Limited 2023 Q4 - Results - Earnings Call Presentation
- Arcturus Therapeutics Holdings Inc. ( ARCT ) Q2 2023 Earnings Call Transcript
- Arcturus Therapeutics: A Beacon Of Hope For Rare Diseases Amid The mRNA Race
- CSL Limited: Fiscal 2024 Outlook In The Spotlight
- Arcturus Therapeutics' joint venture, ARCALIS bags $115M from Japanese government
- Arcturus down 18% on disappointing Q2 results
- uniQure wins $100M milestone from CSL on first gene therapy sale
For further details see:
Arcturus, CSL granted EU review for COVID vaccine